LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Metrics to compare | LNSR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLNSRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.7x | −4.1x | −0.5x | |
PEG Ratio | 0.01 | −0.18 | 0.00 | |
Price/Book | −5.4x | 1.8x | 2.6x | |
Price / LTM Sales | 2.4x | 3.8x | 3.2x | |
Upside (Analyst Target) | 27.1% | 35.4% | 51.1% | |
Fair Value Upside | Unlock | 8.6% | 7.3% | Unlock |